PRESS RELEASE published on 02/20/2025 at 08:01, 9 months 12 days ago SWEF: Seventh Capital Distribution Starwood European Real Estate Finance Ltd announces seventh capital distribution of £46.0 million funded by loan repayment. Compulsory partial redemption of shares at £1.0024 per share. Shareholder information provided Shareholder Information Starwood European Real Estate Finance Ltd Compulsory Redemption Loan Repayment Seventh Capital Distribution
PRESS RELEASE published on 02/20/2025 at 08:00, 9 months 12 days ago SWEF: January 2025 NAV Starwood European Real Estate Finance Ltd announces January 2025 NAV of 100.24p per share. Details on asset values and loan commitments included Net Asset Value Starwood European Real Estate Finance Ltd SWEF January 2025 NAV Loans And Cash Assets
BRIEF published on 01/24/2025 at 08:06, 10 months 11 days ago SWEF: Portfolio Update Dividend Real Estate Debt Portfolio Strategy Impairment Loan Investments
BRIEF published on 01/24/2025 at 08:05, 10 months 11 days ago SWEF Declares Quarterly Dividend for Q4 2024 London Stock Exchange Investment Company Dividend Declaration Annualised Yield Starwood Capital Group
PRESS RELEASE published on 01/24/2025 at 08:01, 10 months 11 days ago SWEF: Portfolio Update Starwood European Real Estate Finance Ltd (SEREF) presents its performance for the quarter, including portfolio update, dividend announcement, cash balances, and credit risk analysis Starwood European Real Estate Finance Ltd Portfolio Update Credit Risk Analysis Dividend Announcement Cash Balances
PRESS RELEASE published on 01/24/2025 at 08:00, 10 months 11 days ago SWEF: Dividend Declaration Starwood European Real Estate Finance Ltd declares quarterly dividend of 1.375 pence for Q4 2024, with an annualised yield of 6.1% based on closing share price on 23 January 2025 London Stock Exchange Dividend Declaration Starwood European Real Estate Finance Ltd Quarterly Dividend 6.1% Yield
BRIEF published on 01/23/2025 at 08:05, 10 months 12 days ago Starwood European Real Estate Finance: December 2024 NAV Update Real Estate Investment NAV Financial Update Starwood
PRESS RELEASE published on 01/23/2025 at 08:00, 10 months 12 days ago SWEF: December 2024 NAV Starwood European Real Estate Finance Ltd (SWEF) reports 100.49p NAV for December 2024. Detailed breakdown of net asset value provided Net Asset Value Financial Report Starwood European Real Estate Finance Ltd SWEF December 2024
BRIEF published on 12/19/2024 at 08:05, 11 months 16 days ago Starwood European Real Estate Finance Announces November 2024 NAV Investment Loans NAV Cash Reserve FX Losses
PRESS RELEASE published on 12/19/2024 at 08:00, 11 months 16 days ago SWEF: November 2024 NAV Starwood European Real Estate Finance Ltd (SWEF) announces unaudited net asset value (NAV) of 99.90p per Ordinary Share as of 30 November 2024 London Stock Exchange Net Asset Value Investment SWEF 30 November 2024
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 36 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 41 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
